Oral GLP-1 currently represented by Rybelsus (oral semaglutide 7mg/14mg daily) for T2DM and advanced by Eli Lilly's orforglipron in late-stage trials is growing at the fastest route of administration CAGR because it fundamentally removes the injection barrier that constrains GLP-1 therapy adoption in the substantial patient population for whom daily or weekly self-injection is a genuine disincentive to treatment initiation or maintenance
Crucially, the researchers explored substituting these expensive growth factors with a small-molecule cocktail, specifically 10 g/mL Vitamin C, 0.1 M Dihexa, and 10 M Forskolin (VDF cocktail), to assess its efficacy in inducing hepatic specification
Laden nanofiber capsules for local malignancy chemotherapy
The delivery included frozen ice packs, organized sharps, and Hims-branded patient information cards
Fish also provides omega-3 fatty acids, which may enhance the effect of GLP-1
Drugs in Context, 4, 212283